Projected Income Statement: cbdMD, Inc.

Forecast Balance Sheet: cbdMD, Inc.

Fiscal Period: September 2020 2021 2022 2023 2024 2025 2026
Net Debt -14.5 -26.2 - - - - -
Change - -80.69% - - - - -
Announcement Date 12/22/20 12/17/21 12/15/22 12/22/23 12/18/24 - -
Estimates

Cash Flow Forecast: cbdMD, Inc.

Fiscal Period: September 2019 2020 2021 2022 2023 2024
CAPEX 1 1.199 1.32 0.342 0.6887 0.2975 0.19
Change - 10.13% -74.09% 101.36% -56.79% -36.14%
Free Cash Flow (FCF) 1 -9.188 -5.318 -7.479 -9.38 -0.6158 5.776
Change - 42.12% -40.63% -25.42% 93.44% 1,038.04%
Announcement Date 12/18/19 12/22/20 12/17/21 12/15/22 12/22/23 12/18/24
1USD in Million
Estimates

Forecast Financial Ratios: cbdMD, Inc.

Fiscal Period: September 2019 2020 2021 2022 2023 2024 2025 2026

Profitability

        
EBITDA Margin (%) - -40.26% -41.81% - - - - -
EBIT Margin (%) - -41.98% -44.1% - -22.88% -8.17% -3.7% -3.5%
EBT Margin (%) - 26.99% -54.61% - -94.96% -18.99% -3.7% -3.5%
Net margin (%) - 29.21% -58.34% - -111.53% -39.54% -12.97% -3.5%
FCF margin (%) - -28.61% -32.45% - - - - -
FCF / Net Income (%) - -97.95% 55.63% - - - - -

Profitability

        
ROA -16.39% -10.4% -10.4% -13.06% -20.33% -15.48% - -
ROE -176.01% 21.67% -25.66% -104.16% -113.4% -67.31% - -

Financial Health

        
Leverage (Debt/EBITDA) - - - - -0.25x - - -
Debt / Free cash flow - - - - -3.06x - - -

Capital Intensity

        
CAPEX / Current Assets (%) - 3.15% 0.77% - 1.23% - - -
CAPEX / EBITDA (%) - -7.83% -1.84% - - - - -
CAPEX / FCF (%) - -11.02% -2.37% - - - - -

Items per share

        
Cash flow per share 1 - - - - - - - -
Change - - - - - - - -
Dividend per Share 1 - - - - - - - -
Change - - - - - - - -
Book Value Per Share 1 - - - - - - - -
Change - - - - - - - -
EPS 1 - 100.8 -169.2 -446.4 -106.6 -14.32 -3.92 -0.96
Change - - -267.86% -163.83% 76.13% 86.56% 72.63% 75.51%
Nbr of stocks (in thousands) - 145 160 168 357 480 782.9 782.9
Announcement Date - 12/22/20 12/17/21 12/15/22 12/22/23 12/18/24 - -
1USD
Estimates
2025 *2026 *
P/E ratio -0.24x -0.99x
PBR - -
EV / Sales 0.03x 0.03x
Yield - -
More valuation ratios * Estimated data

EPS & Dividend

Year-on-year evolution of the PER

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
0.9500USD
Average target price
16.00USD
Spread / Average Target
+1,584.21%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. YCBD Stock
  4. Financials cbdMD, Inc.
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
BENEFIT NOW